Suppr超能文献

[抗代谢药物与烷化剂联合治疗晚期乳腺癌]

[Combination of antimetabolites and alkylating agents in the treatment of advanced breast cancer].

作者信息

Germiniani R, Pipino G, Lavorato F, Bressani Doldi S

出版信息

Minerva Med. 1977 Mar 17;68(13):831-4.

PMID:321989
Abstract

An association of 5-fluoruracyl (or methotrexate) and cyclophosphamide was used in the treatment of 20 cases of hormone-resistant breast cancer. Five objective regressions were obtained. Mean survival here was 28.25 (S.D. 2.87) months, as opposed to 12.75 (S.D. 6.93) months in the remainder. Side-effects of various kinds were noted in 9 patients.

摘要

采用5-氟尿嘧啶(或甲氨蝶呤)与环磷酰胺联合治疗20例激素抵抗性乳腺癌患者。获得了5例客观缓解。此处患者的平均生存期为28.25(标准差2.87)个月,而其余患者为12.75(标准差6.93)个月。9例患者出现了各种副作用。

相似文献

8
Chemotherapy of breast cancer.乳腺癌的化疗
Clin Obstet Gynecol. 1968 Jun;11(2):401-15.
9
Chemotherapy for breast cancer.乳腺癌的化疗
J Reprod Med. 1979 Jul;23(1):3-11.
10

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验